Batimastat

CAS No. 130370-60-4

Batimastat ( BB-94 )

Catalog No. M11219 CAS No. 130370-60-4

Batimastat (BB-94) is a potent, broad spectrum matrix metalloprotease (MMP) inhibitor for MMP-1, MMP-2, MMP-9, MMP-7 and MMP-3 with IC50 of 3 nM, 4 nM, 4 nM, 6 nM and 20 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 102 In Stock
10MG 160 In Stock
25MG 325 In Stock
50MG 518 In Stock
100MG 741 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Batimastat
  • Note
    Research use only, not for human use.
  • Brief Description
    Batimastat (BB-94) is a potent, broad spectrum matrix metalloprotease (MMP) inhibitor for MMP-1, MMP-2, MMP-9, MMP-7 and MMP-3 with IC50 of 3 nM, 4 nM, 4 nM, 6 nM and 20 nM, respectively.
  • Description
    Batimastat (BB-94) is a potent, broad spectrum matrix metalloprotease (MMP) inhibitor for MMP-1, MMP-2, MMP-9, MMP-7 and MMP-3 with IC50 of 3 nM, 4 nM, 4 nM, 6 nM and 20 nM, respectively. Also inhibits the activitity of other metalloproteases, such as ADAM17.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BB-94
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MMP-1| MMP-2| MMP-3| MMP-7| MMP-9
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    130370-60-4
  • Formula Weight
    477.64
  • Molecular Formula
    C23H31N3O4S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:96 mg/mL (200.98 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)[C@H](CSC1=CC=CS1)C(=O)NO |r,c:8,10,26,t:6,24|
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chirivi RG, et al. Int J Cancer, 1994, 58(3), 460-464.
molnova catalog
related products
  • Pectolinarigenin

    Pectolinarigenin possesses anti-inflammatory activity and that they may inhibit eicosanoid formation in inflammatory lesions.

  • Cordycepin

    Cordycepin is a potent inhibitor of IL-1β-induced chemokine production and MMP expression and strongly blocks the p38/JNK/AP-1 signalling pathway in RASFs.

  • Lucideric acid A

    Lucideric acid A is a modulator of JNK and p38 and enhances LPS-induced immune responses in monocytic THP-1 cells possibly via the modulation of p38 and JNK/MAPKs activation.